Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.14.99.29 extracted from

  • Clement, P.M.J.; Hanauske-Abel, H.M.; Wolff, E.C.; Kleinman, H.K.; Park, M.H.
    The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro (2002), Int. J. Cancer, 100, 491-498.
    View publication on PubMed

Application

Application Comment Organism
medicine ciclopirox inhibits cell proliferation and angiogenesis in vitro Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
2,2'-dipyridyl IC50 0.026 mM Homo sapiens
ciclopirox IC50 0.005 mM, complete inhibition above 0.01 mM Homo sapiens
deferiprone IC50 0.117 mM Homo sapiens
desferrioxamine B IC50 0.016 mM Homo sapiens
mimosine IC50 0.191 mM Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens
-
-
-

Source Tissue

Source Tissue Comment Organism Textmining
umbilical vein endothelium
-
Homo sapiens
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
N'-(4-aminobutyl)lysine + electron donor + O2 i.e. deoxyhypusine Homo sapiens N'-(4-amino-2-hydroxybutyl)lysine + oxidized electron donor + H2O i.e. hypusine ?

IC50 Value

IC50 Value IC50 Value Maximum Comment Organism Inhibitor Structure
0.005
-
IC50 0.005 mM, complete inhibition above 0.01 mM Homo sapiens ciclopirox
0.016
-
IC50 0.016 mM Homo sapiens desferrioxamine B
0.026
-
IC50 0.026 mM Homo sapiens 2,2'-dipyridyl
0.117
-
IC50 0.117 mM Homo sapiens deferiprone
0.191
-
IC50 0.191 mM Homo sapiens mimosine